MUMBAI, India, Feb. 13 -- Intellectual Property India has published a patent application (202541124444 A) filed by Saveetha Institute Of Medical And Technical Sciences, Chennai, Tamil Nadu, on Dec. 10, 2025, for 'bioinspired hydroxyapatite based nanogel incorporating cephalexin for enhanced diabetic wound healing.'
Inventor(s) include Dr. Ravithraa B; Dr. S. Rajeshkumar; and Deepak Nallaswamy Veeraiyan.
The application for the patent was published on Feb. 13, under issue no. 07/2026.
According to the abstract released by the Intellectual Property India: "The present invention relates to a bioinspired nanogel fonnulation designed for the treatment of diabetic wounds, wherein cephalexin-loaded hydroxyapatite nanoparticles are synthesized using a green method employing Althaea official is extract and incorporated into a biocompatible gel matrix. The hydroxyapatite nanoparticles serve as a regenerative and osteoconductive carrier, while cephalexin provides sustained antibacterial action against wound-associated pathogens. The nanogel ensures localized, controlled release of the drug, maintains a moist wound environment, and enhances penetration at the wound site. hysico chemicaL characterization confinns anoscale. uniformity stability, and biocompatibility P-reclinical. evaluation in a streptozotocinc. induced diabetic. mice model demonstrates accelerated wound closure, significant reduction in microbial load, and enhanced fibroblast proliferation, angiogenesis, and tissue remodeling compared to conventional treatments. By combining infection control with regenerative bioactivity in a single platfonn, the disclosed nanogel provides a multifunctional and effective therapeutic approach for managing chronic and non-healing diabetic wounds."
Disclaimer: Curated by HT Syndication.
